The use of melatonin in the treatment of chronic fatigue syndrome and circadian rhythm disorders in Parkinson’s disease

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Volumn 2013, Issue 7, 2013, Pages 77-81

  Datieva, V K ^a   Rosinskaya, A V ^a   Levin, O S ^a  

^a Russian Medical Academy of Postgraduate Education Center for Movement Disorders   (Russian Federation)

Author keywords

Chronic fatigue; Circadian rhythms; Melatonin; Non motor signs; Parkinson s disease

Indexed keywords

MELATONIN; CENTRAL DEPRESSANT AGENT;

ARTICLE; ASSESSMENT OF HUMANS; CHRONIC FATIGUE SYNDROME; CIRCADIAN RHYTHM SLEEP DISORDER; CLINICAL ARTICLE; DISEASE SEVERITY; HUMAN; MOOD DISORDER; PARKINSON DISEASE; PARKINSON FATIGUE SCALE; PARKINSONS DISEASE SLEEP SCALE; QUALITY OF LIFE; QUESTIONNAIRE; SPILBERGERS SCALE; CIRCADIAN RHYTHM; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; MALE; MIDDLE AGED; MUSCLE FATIGUE; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; TREATMENT OUTCOME;

CENTRAL NERVOUS SYSTEM DEPRESSANTS; CHRONOBIOLOGY DISORDERS; CIRCADIAN RHYTHM; DOSE-RESPONSE RELATIONSHIP, DRUG; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; MALE; MELATONIN; MIDDLE AGED; MUSCLE FATIGUE; PARKINSON DISEASE; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84887399117     PISSN: 19977298     EISSN: 23094729     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Abe K., Takanashi M., Yanagihara T. Fatigue in patients with Parkinson's disease. Behav Neurol 2000; 12: 103-106.
2. Alves G., Wentzel-Larsen T., Larsen J.P. Is fatigue an independent and persistent symptom in patients with Parkinson disease. Neurology 2004; 63: 1908-1911.
3. Axelrod J. The pineal gland: a neurochemical transducer. Science 1974; 184: 1341-1348.
4. Beck A.T., Ward C., Mendelson M. Beck depression inventory (BDI). Arch Ger Psychiatry 1961; 4: 561-571.
5. Boeve B.F., Silber M.H., Ferman T.J. Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med 2003; 4: 281-284.
6. Brown R.G., Dittner A., Findley L., Wessely S.C. The Parkinson fatigue scale. Parkinsonism Relat Disord 2005; 11: 49-55.
7. Chaudhuri A., Behan P.O. Fatigue and basal ganglia. J Neurol Sci 2000; 179: 34-42.
8. Chaudhuri K.R., Pal S., Di Marco A. et al. The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002; 73: 629-635.
9. Critchley P.S., Malcom G., Malcom P. Fatigue and melatonin in Parkinson`s disease. Neurol Neurosurg Psychiatry 1991; 54: 1: 91-92.
10. Friedman J.H., Friedman H. Fatigue in Parkinson's disease: a nine-year follow-up. Mov Disord 2001; 16: 1120-1122.
11. Friedman J.H., Chou K.L. Sleep and fatigue in Parkinson's disease. Parkinsonism Relat Disord 2004; 10: Suppl 1: S27-S35.
12. Garber C.E., Friedman J.H. Effects of fatigue on physical activity and function in patients with Parkinson's disease. Neurology 2003; 60: 1119-1124.
13. Hagell P., Brundin L. Towards an understanding of fatigue in Parkinsons disease. J Neurol Neurosurg Psychiatr 2009; 2: 23-34.
14. Johns M.W. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991; 50-55.
15. Jou M.J., Peng T.I., Reiter R.J. et al. Visualization of the antioxidative effects of melatonin at the mitochondrial level during oxidative stress-induced apoptosis of rat brain astrocytes. Pineal Res 2004; 37: 55-70.
16. Lincoln G. Melatonin entrainment of circannual rhythms. Chronobiology International 2006; 23: 301-306.
17. Lou J.-S., Kearns G., Oken B., Sexton G., Nutt J. Exacerbated physical fatigue and mental fatigue in Parkinson's disease. Mov Disord 2001; 16: 190- 196.
18. Nasreddine Z.S., Phillips N.A., Bedirian V. et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53: 695-699.
19. Peto V., Jenkinson C., Fitzpatrick R., Greenhall R. The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res 1995; 4: 241-248.
20. Sandyk R. Pineal melatonin functions: possible relevance to Parkinson's disease. Int J Neurosci 1990; 50: 37-53.
21. Spielberger C.D., Gorsuch R.L., Lushene R. et al. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press 1983; 160.